CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Company Charles River Laboratories International, Inc. Berne S.E.
Equities
RV6
US1598641074
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | -.--% |
| 06-13 | Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270 | MT |
| 06-07 | The job report just threw a spanner in the works |  |
Business Summary
- discovery and safety assessment services (63.4%): discovery services for the identification, screening and selection of main compounds for the development of new drug candidates, and in vivo and in vitro testing, including pharmacokinetic, bioanalytical, metabolic, toxicological and pathological studies, for the safety assessment of pharmaceutical products, medical devices, animal health products, chemical and agrochemical products and biocides;
- development and sale of research models and related services (19.2%): mice, rats, immunodeficient models, rabbits, guinea pigs, hamsters, etc. The group also offers primary cells and specialized products (bioconservation products, freezing media for cell cultures, antigens, peptides, humanized mouse models, etc.) for the development and manufacture of new cell therapies ;
- development of solutions used in drug manufacturing processes (17.5%): products and services for microbiological testing, in vitro testing, endotoxin testing, microbial identification, development, manufacturing of avian vaccines, etc. The group also offers contract manufacturing services for cell and gene therapies.
Net sales break down by source of income between sales of services (83.3%) and sales of products (16.7%).
Net sales are distributed geographically as follows: the United States (56.8%), Europe (26%), Canada (11.8%), Asia/Pacific (4.9%) and other (0.4%).
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Discovery and Safety Assessment
63.3
%
| 2,447 | 61.6 % | 2,616 | 63.3 % | +6.88% |
Research Models and Services
19.2
%
| 739 | 18.6 % | 792 | 19.2 % | +7.19% |
Manufacturing Solutions
17.5
%
| 790 | 19.9 % | 721 | 17.5 % | -8.63% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
56.8
%
| 2,342 | 58.9 % | 2,347 | 56.8 % | +0.23% |
Europe
26.1
%
| 1,032 | 26.0 % | 1,077 | 26.1 % | +4.34% |
Canada
11.8
%
| 399 | 10.0 % | 487 | 11.8 % | +22.14% |
Asia Pacific
4.9
%
| 193 | 4.8 % | 201 | 4.9 % | +4.15% |
Other
0.4
%
| 10 | 0.3 % | 17 | 0.4 % | +69.19% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 31/12/75 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 24/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 31/03/89 |
Julie Frearson
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/13 |
Mark Mintz
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/21 |
| Compliance Officer | - | 31/01/01 | |
Matthew Daniel
CMP | Compliance Officer | - | 31/12/04 |
Todd Spencer
IRC | Investor Relations Contact | - | 31/05/18 |
Michael Knell
AUD | Comptroller/Controller/Auditor | 47 | 25/04/17 |
John C. Ho
PRN | Corporate Officer/Principal | 64 | 31/12/11 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 31/12/02 |
Virginia Wilson
BRD | Director/Board Member | 68 | 30/09/19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 24/01/11 |
Deborah Kochevar
BRD | Director/Board Member | 67 | 28/10/08 |
Richard Wallman
BRD | Director/Board Member | 73 | 23/01/11 |
James Foster
CEO | Chief Executive Officer | 73 | 31/12/75 |
Martin MacKay
BRD | Director/Board Member | 68 | 04/07/17 |
Craig Thompson
BRD | Director/Board Member | 71 | 01/12/13 |
Nancy Andrews
BRD | Director/Board Member | 65 | 27/02/20 |
George Llado
BRD | Director/Board Member | 58 | 15/10/20 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 51,553,687 | 51,001,552 ( 98.93 %) | 42,000 ( 0.0815 %) | 98.93 % |
Company contact information
Charles River Laboratories International, Inc.
251 Ballardvale Street
01887, Wilmington
+781 222 6000
http://www.criver.com
Group companies
| Name | Category and Sector |
|---|---|
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. |
Miscellaneous Commercial Services
|
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. |
Medical Specialties
|
Charles River Discovery Research Services Finland Oy
 Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. |
Miscellaneous Commercial Services
|
Charles River Laboratories Japan, Inc.
 Charles River Laboratories Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The Jackson Laboratory, Charles River Laboratories Japan, Inc. provides laboratory testing and research services. The company is based in Yokohama, Japan. The Japanese company was founded in 1972. Charles River Laboratories Japan was acquired by The Jackson Laboratory from Charles River Laboratories International, Inc. on October 12, 2021 for $0.56 million. |
Miscellaneous Commercial Services
|
Charles River Laboratories Holdings Ltd.
 Charles River Laboratories Holdings Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., Charles River Laboratories Holdings Ltd. is a British company that provides investment services. The company is based in Margate, UK and was founded in 1999. |
Financial Conglomerates
|
Charles River UK Ltd.
 Charles River UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1969, Charles River UK Ltd. is a subsidiary of Charles River Laboratories International, Inc. The company is based in Margate, UK and engages in research and experimental development on biotechnology. |
Miscellaneous Commercial Services
|
Charles River Laboratories Preclinical Services Montreal ULC
 Charles River Laboratories Preclinical Services Montreal ULC Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Laboratories Preclinical Services Montreal ULC is a company based in Senneville, Canada. |
Miscellaneous Commercial Services
|
Charles River Nederland BV
 Charles River Nederland BV Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Nederland BV is a company based in Leiden, the Netherlands. |
Miscellaneous Commercial Services
|
Ballardvale CV
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +40.80% | 53.67B | |
| +35.79% | 38.86B | |
| -8.05% | 38.76B | |
| -8.98% | 27.27B | |
| +10.69% | 25.91B | |
| -16.21% | 20.29B | |
| +31.00% | 12.78B | |
| +28.51% | 12.18B | |
| -1.67% | 11.96B |
- Stock Market
- Equities
- CRL Stock
- RV6 Stock
- Company Charles River Laboratories International, Inc.